Article
Prediabetes Blunts CD26/DPP4 Genetic Control of Postprandial Glycemia and Insulin Secretion
2021-07-30
Abstract excerpt
<h4>ABSTRACT</h4> <h4>Aims/hypothesis</h4> Imbalances in glucose metabolism are hallmarks of clinically silent prediabetes representing dysmetabolism trajectories leading to type 2 diabetes (T2D). CD26/DPP4 is a clinically proven molecular target of diabetes-controlling drugs but the CD26 gene control of disglycemia is unsettled. <h4>Methods</h4> We dissected the genetic control of postprandial glycemic and insuli...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 80dbb023-2428-52b6-8619-c807bd73fc98
- DOI
- 10.1101/2021.07.24.21261077
